CME: Closing the Circle in Hypoactive Sexual Desire Disorder: Communication, Diagnosis, & Treatment

Closing the Circle in Hypoactive Sexual Desire Disorder: Communication, Diagnosis, & Treatment

Closing the Circle in Hypoactive Sexual Desire Disorder: Communication, Diagnosis, & Treatment

Hypoactive sexual desire disorder is the most common female sexual dysfunction…so why is it persistently underdiagnosed and undermanaged?

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The underdiagnosis and undermanagement of hypoactive sexual desire disorder is in large part due to clinicians’ reluctance to raise issues of sexual health and functioning in their female patients, in addition to a lack of awareness of diagnostic screeners available and evolving therapeutic approaches. 

    To help close these gaps in care, this discussion will identify the symptoms of HSDD and the barriers clinicians face that inhibit the appropriate diagnosis and management of this condition. The faculty will also identify the screening tools that allow for accurate diagnosis of HSDD as well as the therapeutic modalities currently available and under clinical development to manage HSDD, including their benefits and potential side effects.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Lee Philip Shulman, MD, FACOG, FACMG
    The Anna Ross Lapham Professor and Chief
    Division of Clinical Genetics
    Feinberg School of Medicine of Northwestern University
    Chicago, IL

    Consulting Fees: Natera, Sequenom Inc., Sera
    Commercial Interest Speakers Bureau: Sequenom Inc.
    Contracted Research: Natera, Sequenom Inc. 


    Sheryl A. Kingsberg, PhD
    Chief, Division of Behavioral Medicine
    Department of OB/GYN
    University Hospitals Cleveland Medical Center
    Professor, Departments of Reproductive Biology and Psychiatry
    Case Western Reserve University School of Medicine
    MacDonald Women’s Hospital
    Cleveland, OH

    Consulting Fees: AMAG Pharmaceuticals, Dare, Emotional Brain, Endoceutics, Palatin, Strategic Science Technologies, Valeant Pharmaceuticals                                                        
    Commercial Interest Speakers Bureau: AMAG Pharmaceuticals, Therapeutics MD                                            Contracted Research: AMAG Pharmaceuticals, Endoceutics, Palatin           
    Ownership Interest: Viveve

    David J. Portman, MD
    Director Emeritus, Columbus Center for Women’s Health Research
    Adjunct Instructor of Obstetrics and Gynecology
    Ohio State University
    Columbus, OH

    Salary: Sermonix Pharmaceuticals 
    Consulting Fees: AMAG Pharmaceuticals, ITF  
    Commercial Interest Speakers Bureau: AMAG Pharmaceuticals 
    Ownership Interest: Sermonix Pharmaceuticals 

    Reviewers/Content Planners/Authors:

    • Barry A. Fiedel, PhD has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
    • Robert Schneider, MSW has nothing to disclose.
  • Learning Objectives

    The goal of this activity is to enable effective collaboration and communication between the members of the professional teams who care for patients with HSDD.  After participating in this educational activity, participants should be better able to:

    • Identify the symptoms of hypoactive sexual desire disorder (HSDD)
    • Cite barriers in their clinical practice that inhibit the appropriate diagnosis and management of HSDD
    • Describe the components of a comprehensive sexual history
    • Identify the screening tools that allow for accurate diagnosis of HSDD
    • Explain causal factors for HSDD and common co-morbid conditions
    • Identify the therapeutic modalities currently available, and under clinical development, to manage HSDD including their benefits and potential side effects 
  • Target Audience

    This activity is designed to meet the educational needs of Ob/Gyns, Primary Care Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Sex Therapists, Marriage Therapists, Sexuality Educators and other members of the interprofessional team who are involved in the management of patients with HSDD.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from AMAG Pharmaceuticals, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments


We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free